Effect of cosyntropin during adrenal venous sampling on subtype of primary aldosteronism: analysis of surgical outcome

Eur J Endocrinol. 2020 Mar;182(3):265-273. doi: 10.1530/EJE-19-0860.

Abstract

Objectives: We investigated the clinical significance of ACTH stimulation during adrenal venous sampling (AVS) by surgical outcome of primary aldosteronism (PA).

Design: Multicenter retrospective study by Japan PA study.

Method: We allocated 314 patients with both basal and ACTH-stimulated AVS data who underwent adrenalectomy to three groups: basal lateralization index (LI) ≥2 with ACTH-stimulated LI ≥4 on the ipsilateral side (Unilateral (U) to U group, n = 245); basal LI <2 with ACTH-stimulated LI ≥4 (Bilateral (B) to U group, n = 15); and basal LI ≥2 with ACTH-stimulated LI <4 (U to B group, n = 54). We compared surgical outcomes among the groups using the Primary Aldosteronism Surgical Outcome (PASO) criteria.

Results: Compared with U to U group, U to B group had poor clinical and biochemical outcomes and low rates of adrenal adenoma as pathological findings (P = 0.044, 0.006, and 0.048, respectively), although there were no significant differences between U to U and B to U groups. All patients in U to B group with clinical and biochemical benefits, however, had adrenal adenoma as pathological findings and could be well differentiated from those with poor surgical outcomes via basal LI (>8.3), but not ACTH-stimulated LI. These results were similar even when we defined each group based on a cut-off value of 4 for basal LI.

Conclusions: Although PA patients in U to B group had worse surgical outcomes than did those in U to U group, basal LI could discriminate among patients with better surgical outcomes in U to B group.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Adenoma / pathology
  • Adrenal Gland Neoplasms / pathology
  • Adrenal Glands / drug effects
  • Adrenal Glands / metabolism*
  • Adrenalectomy
  • Adrenocortical Adenoma / pathology
  • Adult
  • Aged
  • Cohort Studies
  • Cosyntropin / pharmacology*
  • Female
  • Humans
  • Hyperaldosteronism / surgery*
  • Male
  • Middle Aged
  • Prognosis
  • Registries
  • Retrospective Studies
  • Sensitivity and Specificity
  • Treatment Outcome

Substances

  • Cosyntropin